ABX PENTRA Calcium CP Reagent, Model # A11A01633 Calcium plays an essential role in many cell functions: intracellularly in muscle contraction and glycogen metabolism, extracellularly, in bone mineralization, in blood coagulation and in transmission of nerve impulses. Calcium is present in plasma in three forms: free, bound to proteins or complexed with anions as phosphate, citrate and bicarbonate. Under physiological conditions, calcium balance is determined by the relationship between calcium intake and calcium absorption and excretion. Urinary excretion is an important determinant of calcium retention in the body. Decreased total calcium levels can be associated with diseases of the bone apparatus (especially osteoporosis), kidney diseases (especially under dialysis), defective intestinal absorption and hypoparathyroidism. Increased total calcium can be measured in hyperparathyroidism, malignant diseases with metastases and sarcoidosis. Calcium measurements also help in monitoring of calcium supplementation mainly in the prevention of osteoporosis.
Publicado el 2 de octubre de 2013 · Inicio del retiro: 6 de septiembre de 2013
Resumen
FDA registra el retiro Z-2280-2013 de dispositivos médicos de Clase III, publicado el 2 de octubre de 2013 e iniciado el 6 de septiembre de 2013. Empresa responsable: Horiba Instruments, Inc dba Horiba Medical; Estado: Finalizado; Cantidad reportada: 2,658 units ( 1240 US 1418 OUS ); Lote: Lot/Serial #(s): 014664503. La Clase III indica que no es probable que el producto cause consecuencias adversas para la salud.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
HORIBA Medical is informing all PENTRA 200 and PENTRA 400 customers of a potential for reporting incorrect calcium results when using the ABX PENTRA CALCIUM CP reagent.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Horiba Instruments, Inc dba Horiba Medical
- Distribuidor
- Worldwide Distribution - USA including the country of Canada.
- Lote
- Lot/Serial #(s): 014664503
- Clasificación de riesgo
- Class III
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAABX Pentra Micro ALBUMIN 2 CP, Serum/Plasma, REF 1300032563 The device is intended for use in conjunction with4 de julio de 2018
- FDAABX PENTRA Magnesium RTU Reagent, Part No. A11A01646 Product Usage: ABX PENTRA Magnesium RTU reagent with1 de octubre de 2014
- FDADevice Name: ABX PENTRA ML Model/Part #(s): A11A01652 Lot/Serial #(s): N/A Software Version(s): All versions19 de marzo de 2014
- FDAABX PENTRA Multical. ABX PENTRA N Control. ABX PENTRA P Control. The ABX PENTRA 400 and PC200 are benchtop12 de marzo de 2014
- FDASmartSite Low Sorbing Infusion Set, Model#72313E The SmartSite Low Sorbing Infusion Sets are used to2 de octubre de 2013
- FDACareFusion Gravity Set, Model #44000-07 The CareFusion Gravity Sets are used to administer fluid and2 de octubre de 2013
Preguntas sobre este retiro
¿ABX PENTRA Calcium CP Reagent, Model # A11A01633 Calcium plays an essential role in many cell functions: intracellularly in muscle contraction and glycogen metabolism, extracellularly, in bone mineralization, in blood coagulation and in transmission of nerve impulses. Calcium is present in plasma in three forms: free, bound to proteins or complexed with anions as phosphate, citrate and bicarbonate. Under physiological conditions, calcium balance is determined by the relationship between calcium intake and calcium absorption and excretion. Urinary excretion is an important determinant of calcium retention in the body. Decreased total calcium levels can be associated with diseases of the bone apparatus (especially osteoporosis), kidney diseases (especially under dialysis), defective intestinal absorption and hypoparathyroidism. Increased total calcium can be measured in hyperparathyroidism, malignant diseases with metastases and sarcoidosis. Calcium measurements also help in monitoring of calcium supplementation mainly in the prevention of osteoporosis. fue retirado del mercado?
Sí. FDA publicó el retiro Z-2280-2013 el 2 de octubre de 2013. Peligro reportado: HORIBA Medical is informing all PENTRA 200 and PENTRA 400 customers of a potential for reporting incorrect calcium results when using the ABX PENTRA CALCIUM CP reagent.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter